Latest Commercialization News

Vection Technologies has landed a $1.2 million grant to lead an innovative XR and AI digital twin project aimed at transforming real-time product intelligence in food and beverage manufacturing.

Blue Star Helium has successfully drilled the Jackson 2 well to total depth at its Galactica project in Colorado, confirming strong natural gas flow and advancing the project toward commercial production.

Altech Batteries has launched an operational pilot plant in Germany producing its proprietary Silumina Anodes, promising a 50% increase in lithium-ion battery capacity with improved longevity.

Foresta Group Holdings’ subsidiary partners with New Zealand’s EECA to explore geothermal steam for its flagship biomass facility, aiming to boost sustainability and efficiency.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Anax Metals has locked in a $3.3 million convertible note investment from Mineral Development Partners, with conditional commitments for up to $100 million to advance the Whim Creek Project and establish a Pilbara base metals hub.

Conrad Asia Energy has successfully raised approximately A$9 million through a two-tranche placement, with strong insider participation, to fund key milestones in its flagship Mako gas development and other projects.

Critica Limited has secured drilling approvals and government funding to explore high-grade heavy rare earth elements at its Aurora and Juno satellite prospects near the flagship Jupiter deposit in Western Australia.

Synertec Corporation reports a 7.7% revenue increase in FY25 Q3, highlights robust Powerhouse technology performance during extreme weather, and secures a US patent for its LNG Custody Transfer System.

Neurotech International has reported excellent safety and tolerability for its lead drug NTI164 in 28-day GLP toxicology studies, paving the way for regulatory submissions and longer-term clinical development.

4DMedical has landed a significant commercial contract with Intermountain Health to deploy its FDA-cleared Pulmonary Hypertension Analysis (PHA™) product, marking a key milestone in its U.S. expansion through a strategic Microsoft-backed partnership.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.